Current management of bowel failure due to Crohn's disease in Spain: Results of a GETECCU survey

被引:1
|
作者
Cristina, Suarez Ferrer [1 ,2 ]
Dolores Martin-Arranz, Maria [1 ,2 ]
Martin-Arranz, Eduardo [1 ,2 ]
Rodriguez Morata, Francisco [3 ]
Lopez Garcia, Alicia [4 ]
Benitez Cantero, Jose Manuel [5 ]
Mesonero Gismero, Francisco [6 ]
Barreiro-de Acosta, Manuel [7 ]
机构
[1] Hosp Univ La Paz, Serv Gastroenterol, Madrid, Spain
[2] Hosp La Paz Inst Hlth Res IdiPaz, Madrid, Spain
[3] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Barcelona, Spain
[4] Hosp Clin Univ San Carlos, Madrid, Spain
[5] Hosp Univ Reina Sofia, Madrid, Spain
[6] Hosp Univ Ramon & Cajal, Madrid, Spain
[7] Hosp Univ Santiago De Compostela, Santiago De Compostela, La Coruna, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2023年 / 46卷 / 06期
关键词
Crohns ' disease; Intestinal failure; Teduglutide; CHRONIC INTESTINAL FAILURE; SURGICAL-MANAGEMENT; TEDUGLUTIDE; NUTRITION;
D O I
10.1016/j.gastrohep.2022.10.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Intestinal failure is a rare pathology which requires knowledge and highly spe-cialized multidisciplinary management. Crohn's disease (CD) being one of the most frequent causes in adults. Material and methods: Survey format study carried out within the GETECCU group, included closed format questions about the diagnosis, management and current knowledge of intestinal failure in CD. Results: Forty-nine doctors participated, belonging to different Spanish centers (19 cities). It was considered that a patient suffered from intestinal failure, in 67.3% (33/49 surveyed) when there was a disorder malabsorptive associated regardless of the intestinal length resected, with surgeries resective ileal repeated (40.8%, 20/49), the most frequent cause. It highlights frequent ignorance about the pathology (24.5%) did not know if there were patients in their center and also 40% did not know the pharmacological treatment. A total of 228 patients were registered for follow-up due to intestinal failure of any aetiology, 89 patients (39.5%) were identified with CD. Regarding the therapeutic management of patients with CD and intestinal failure (72.5%) were receiving total parenteral nutrition (NTP) and 24 patients (27%) with teduglutide. Regarding the response to the drug: 37.5% had no response to teduglutide, 37.5% partial response (reduce NTP) and 25% good response (withdrawal of home NTP). In questions related to knowledge about intestinal failure, it was considered limited (53.1%) or very limited (12.2%) by the surveyed. Conclusion: It is necessary to carry out a combined management of intestinal failure and CD in the context of a multidisciplinary approach. (c) 2022 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 50 条
  • [1] Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) survey on the management of patients with inflammatory bowel disease
    Ginard, Daniel
    Ricote, Mercedes
    Nos, Pilar
    Pejenaute, M. Elena
    Sans, Miquel
    Fontanillas, Noelia
    Acosta, Manuel Barreiro-de
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (08): : 647 - 656
  • [2] Inflammatory bowel disease and exercise: results of a Crohn's and Colitis UK survey
    Chan, D.
    Robbins, H.
    Rogers, S.
    Clark, S.
    Poullis, A.
    FRONTLINE GASTROENTEROLOGY, 2014, 5 (01) : 44 - 48
  • [3] Inflammatory bowel disease in immigrants to Spain: results of the EIIMIGRA study from GETECCU (ENEIDA registry)
    Gutierrez Casbas, A.
    Zapater, P.
    Ricart, E.
    Gonzalez-Vivo, M.
    Gordillo, J.
    Olivares, D.
    Vera-Mendoza, I.
    Manosa, M.
    Gisbert, J. P.
    Aguas, M.
    Sanchez-Rodriguez, E.
    Bosca, M.
    Laredo, V.
    Camps, B.
    Marin-Jimenez, I.
    Zabana, Y.
    Martin-Arranz, M. D.
    Munoz, R.
    Navarro-Llavat, M.
    Sierra, E.
    Madero, L.
    Vela, M.
    Perez-Calle, J.
    Sainz, E.
    Calvet, X.
    Sicilia, B.
    Morales, V.
    Bermejo, F.
    Fernandez-Salazar, L.
    Van Domselaar, M.
    De Castro, L.
    Rodriguez, C.
    Munoz-Villafranca, C.
    Lorente, R.
    Rivero, M.
    Iglesias, E.
    Herreros, B.
    Barreiro-de-Acosta, M.
    Domenech, E.
    Frances, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S567 - S568
  • [4] Heterogeneity in the Endoscopic Management of Crohn's Disease Associated Strictures: Results From an International Inflammatory Bowel Disease Specialist Survey
    Bettenworth, Dominik
    Lopez, Rocio
    Hindryckx, Pieter
    Levesque, Barrett G.
    Rieder, Florian
    GASTROENTEROLOGY, 2015, 148 (04) : S459 - S460
  • [5] Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients
    Barreiro-de Acosta, Manuel
    Marin-Jimenez, Ignacio
    Panadero, Abel
    Guardiola, Jordi
    Canas, Mercedes
    Gobbo Montoya, Milena
    Modino, Yolanda
    Alcain, Guillermo
    Maia Bosca-Watts, Marta
    Calvet, Xavier
    Casellas, Francesc
    Chaparro, Maria
    Fernandez Salazar, Luis
    Ferreiro-Iglesias, Rocio
    Ginard, Daniel
    Iborra, Marisa
    Mancenido, Noemi
    Manosa, Miriam
    Merino, Olga
    Rivero, Montserrat
    Roncero, Oscar
    Sempere, Laura
    Vega, Pablo
    Zabana, Yamile
    Minguez, Miguel
    Nos, Pilar
    Gisbert, Javier P.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (02): : 118 - 127
  • [6] Challenges in Crohn's disease: Intestinal failure and short bowel syndrome in Crohn's disease
    Soop, Mattias
    SEMINARS IN COLON AND RECTAL SURGERY, 2020, 31 (02)
  • [7] Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of tiopurines in inflammatory bowel disease
    Berrnejo, Fernando
    Aguas, Mariam
    Chaparro, Maria
    Domenech, Eugeni
    Echarri, Ana
    Garcia-Planella, Esther
    Guerra, Ivan
    Gisbert, Javier P.
    Lopez-Sanroman, Antonio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (03): : 205 - 221
  • [8] Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease
    Gomolion, Fernando
    Rubio, Saioa
    Charro, Mara
    Garcia-Lopez, Santiago
    Munoz, Fernando
    Gisbert, Javier P.
    Domenech, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2015, 38 (01): : 24 - 30
  • [9] Management of growth failure in Crohn's disease
    WalkerSmith, JA
    ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 75 (04) : 351 - 354
  • [10] Results of the first survey for the current status of inflammatory bowel disease management in Asian countries
    Kim, Ji Won
    INTESTINAL RESEARCH, 2016, 14 (03) : 199 - 201